Response to "DPYD genotyping panels: Impact of population diversity"
- PMID: 38637962
- PMCID: PMC11026573
- DOI: 10.1111/cts.13806
Response to "DPYD genotyping panels: Impact of population diversity"
Conflict of interest statement
A.J.T. is supported in part by RPRD Diagnostics LLC.
Comment on
-
Updated DPYD HapB3 haplotype structure and implications for pharmacogenomic testing.Clin Transl Sci. 2024 Jan;17(1):e13699. doi: 10.1111/cts.13699. Clin Transl Sci. 2024. PMID: 38129972 Free PMC article.
-
DPYD genotyping panels: Impact of population diversity.Clin Transl Sci. 2024 Apr;17(4):e13805. doi: 10.1111/cts.13805. Clin Transl Sci. 2024. PMID: 38634417 Free PMC article. No abstract available.
References
-
- Clinical Pharmacogenetics Implementation Consortium (CPIC). https://cpicpgx.org/guidelines/guideline‐for‐fluoropyrimidines‐and‐dpyd/
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources